Alessandro Gozzi1, Apar Jain2,
Valerio Crestan1, Adam J. Schwarz1,3, Theodoros
Tsetsenis2, Graham Sheridan4, Cornelius T. Gross4,
Angelo Bifone1
1Neuroscience CEDD, GlaxoSmithKline,
Verona, Verona, Italy, Italy; 2Mouse Biology Unit,, EMBL, ,
Monterotondo, , Italy, Italy; 3 Translational Imaging , Eli Lilly
, Indianapolis, IN, United States; 4Mouse Biology Unit,, EMBL,,
Monterotondo,, Italy, Italy
Functional
MRI methods have been widely applied to map regional changes in brain
activity elicited by somatosensory stimuli, complex cognitive or emotional
tasks, and pharmacological challenges. Here we describe and demonstrate the
use of fMRI to map the functional effects of rapid and reversible
pharmacogenetic silencing of selected neuronal populations focally expressed
in specific regions of the mouse brain. In combination with behavioural
observations, this novel approach provides a powerful means to assess the
functional role of these neurons, to resolve the brain circuitry they are
elements of, and to establish their implication in behavioural control